These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3864060)

  • 1. Volunteer blood donors for a cell pheresis programme.
    Woodfield DG; Ramirez A; Everard A; Kent J
    N Z Med J; 1985 Oct; 98(789):904-6. PubMed ID: 3864060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Group for the Study of Immunohematology and Hemotherapy. Norms for the selection and care of platelet and granulocyte donors for pheresis technics].
    Puig LL; Gelabert A; Durán-Suárez JR
    Sangre (Barc); 1984; 29(4-A):473-4. PubMed ID: 6505932
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple pheresis - effect on the donor.
    Ho W
    Prog Clin Biol Res; 1981; 65():91-9. PubMed ID: 7330074
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems in blood donors in plasmapheresis and cytopheresis].
    Fiala J
    Vnitr Lek; 1982 Feb; 28(2):182-8. PubMed ID: 7064373
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems in donor recruitment.
    Grindon AJ
    Prog Clin Biol Res; 1982; 88():181-7. PubMed ID: 7100209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood donation (selection of donors, protection of donors and recipients, collection technics, possible complications, methods of blood donation].
    Wegener S
    Z Arztl Fortbild (Jena); 1982 Feb; 76(3):77-82. PubMed ID: 7043917
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparability of haematological and biochemical parameters before and after apheresis of volunteer donors.
    Lewis SM; Anderson NA; Pamphilon DH
    Vox Sang; 1991; 61(1):78. PubMed ID: 1949718
    [No Abstract]   [Full Text] [Related]  

  • 8. Component therapy.
    Schmidt PJ
    Int Anesthesiol Clin; 1982; 20(4):23-43. PubMed ID: 6816740
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet collection in the dual stage channel.
    Hester JP; Kellogg RM; Mulzet AP
    Prog Clin Biol Res; 1982; 88():143-51. PubMed ID: 7100206
    [No Abstract]   [Full Text] [Related]  

  • 10. A critical review of platelet yield by Haemonetics 30 . Based on literature and own observations.
    Rosenkvist J; Holsøe E; Freiesleben E; Sørensen H
    Scand J Haematol; 1980 Aug; 25(2):165-70. PubMed ID: 7466305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
    Morse EE; Hohnadel DC; Genco P; Katz AJ
    Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting reticulocyte enrichment by density gradient ultracentrifugation.
    Jun G; Seoh JY; Jung YJ; Jeon CH; Im JS; Park JW
    Acta Haematol; 2009; 121(4):207-11. PubMed ID: 19468206
    [No Abstract]   [Full Text] [Related]  

  • 13. Increasing hemoglobin oxygen saturation levels in sickle trait donor whole blood prevents hemoglobin S polymerization and allows effective white blood cell reduction by filtration.
    Stroncek DF; Byrne KM; Noguchi CT; Schechter AN; Leitman SF
    Transfusion; 2004 Sep; 44(9):1293-9. PubMed ID: 15318851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hepatitis C among New Zealand blood donors.
    Ghosh S
    N Z Med J; 1998 Apr; 111(1064):151-2. PubMed ID: 9612479
    [No Abstract]   [Full Text] [Related]  

  • 15. Influences of general and traditional Chinese beliefs on the decision to donate blood among employer-organized and volunteer donors in Beijing, China.
    Tison GH; Liu C; Ren F; Nelson K; Shan H
    Transfusion; 2007 Oct; 47(10):1871-9. PubMed ID: 17880614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis HGV/GBV-C in New Zealand blood donors.
    Woodfield G
    N Z Med J; 1997 Mar; 110(1040):108. PubMed ID: 9137316
    [No Abstract]   [Full Text] [Related]  

  • 17. [Isolation and use of thrombocyte and leukocyte concentrates].
    Kalinin NN
    Probl Gematol Pereliv Krovi; 1980 Oct; 25(10):50. PubMed ID: 6999495
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on blood component transfusion with continuous blood cell separator (IBM 2997). Part 1 : Effects of blood component extraction on donors (author's transl)].
    Toki H; Ishikawa M
    Rinsho Ketsueki; 1981 Oct; 22(10):1525-30. PubMed ID: 7334597
    [No Abstract]   [Full Text] [Related]  

  • 19. How free of residual cells and cell antigens is human blood plasma? A comparison of different production methods of human blood plasma and the risk of the products for patients.
    Wurm K; Rummler S; Barz D
    Transfus Apher Sci; 2008 Apr; 38(2):149-57. PubMed ID: 18348910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron status and risk-profiling for deficiency in New Zealand blood donors.
    Badami KG; Taylor K
    N Z Med J; 2008 May; 121(1274):50-60. PubMed ID: 18535646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.